These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27163177)

  • 1. An Integrative Proteomic Approach Identifies Novel Cellular SMYD2 Substrates.
    Ahmed H; Duan S; Arrowsmith CH; Barsyte-Lovejoy D; Schapira M
    J Proteome Res; 2016 Jun; 15(6):2052-9. PubMed ID: 27163177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics.
    Olsen JB; Cao XJ; Han B; Chen LH; Horvath A; Richardson TI; Campbell RM; Garcia BA; Nguyen H
    Mol Cell Proteomics; 2016 Mar; 15(3):892-905. PubMed ID: 26750096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non-Histone Substrates.
    Weirich S; Schuhmacher MK; Kudithipudi S; Lungu C; Ferguson AD; Jeltsch A
    Chembiochem; 2020 Jan; 21(1-2):256-264. PubMed ID: 31612581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation.
    Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z
    J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of substrates for a SET domain lysine methyltransferase predicted by multistate computational protein design.
    Lanouette S; Davey JA; Elisma F; Ning Z; Figeys D; Chica RA; Couture JF
    Structure; 2015 Jan; 23(1):206-215. PubMed ID: 25533488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase.
    Abu-Farha M; Lambert JP; Al-Madhoun AS; Elisma F; Skerjanc IS; Figeys D
    Mol Cell Proteomics; 2008 Mar; 7(3):560-72. PubMed ID: 18065756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of p53 activity by Smyd2-mediated methylation.
    Huang J; Perez-Burgos L; Placek BJ; Sengupta R; Richter M; Dorsey JA; Kubicek S; Opravil S; Jenuwein T; Berger SL
    Nature; 2006 Nov; 444(7119):629-32. PubMed ID: 17108971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins.
    Xu S; Zhong C; Zhang T; Ding J
    J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function.
    Voelkel T; Andresen C; Unger A; Just S; Rottbauer W; Linke WA
    Biochim Biophys Acta; 2013 Apr; 1833(4):812-22. PubMed ID: 23047121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.
    Nguyen H; Allali-Hassani A; Antonysamy S; Chang S; Chen LH; Curtis C; Emtage S; Fan L; Gheyi T; Li F; Liu S; Martin JR; Mendel D; Olsen JB; Pelletier L; Shatseva T; Wu S; Zhang FF; Arrowsmith CH; Brown PJ; Campbell RM; Garcia BA; Barsyte-Lovejoy D; Mader M; Vedadi M
    J Biol Chem; 2015 May; 290(22):13641-53. PubMed ID: 25825497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2.
    Abu-Farha M; Lanouette S; Elisma F; Tremblay V; Butson J; Figeys D; Couture JF
    J Mol Cell Biol; 2011 Oct; 3(5):301-8. PubMed ID: 22028380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches and Guidelines for the Identification of Novel Substrates of Protein Lysine Methyltransferases.
    Kudithipudi S; Jeltsch A
    Cell Chem Biol; 2016 Sep; 23(9):1049-1055. PubMed ID: 27569752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.
    Li LX; Zhou JX; Calvet JP; Godwin AK; Jensen RA; Li X
    Cell Death Dis; 2018 Feb; 9(3):326. PubMed ID: 29487338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of substrate methylation and inhibition of SMYD2.
    Ferguson AD; Larsen NA; Howard T; Pollard H; Green I; Grande C; Cheung T; Garcia-Arenas R; Cowen S; Wu J; Godin R; Chen H; Keen N
    Structure; 2011 Sep; 19(9):1262-73. PubMed ID: 21782458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational Dynamics of Lysine Methyltransferase Smyd2. Insights into the Different Substrate Crevice Characteristics of Smyd2 and Smyd3.
    Chandramouli B; Chillemi G
    J Chem Inf Model; 2016 Dec; 56(12):2467-2475. PubMed ID: 27959541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ribosomal protein eL21 interacts with the protein lysine methyltransferase SMYD2 and regulates its steady state levels.
    Khan MIK; Charles RCM; Ramachandran R; Gupta S; Govindaraju G; Mishra R; Rajavelu A; Coumar MS; Chavali S; Dhayalan A
    Biochim Biophys Acta Mol Cell Res; 2021 Aug; 1868(9):119079. PubMed ID: 34147559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins.
    Rathert P; Dhayalan A; Ma H; Jeltsch A
    Mol Biosyst; 2008 Dec; 4(12):1186-90. PubMed ID: 19396382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex.
    Brown MA; Sims RJ; Gottlieb PD; Tucker PW
    Mol Cancer; 2006 Jun; 5():26. PubMed ID: 16805913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency.
    Boehm D; Jeng M; Camus G; Gramatica A; Schwarzer R; Johnson JR; Hull PA; Montano M; Sakane N; Pagans S; Godin R; Deeks SG; Krogan NJ; Greene WC; Ott M
    Cell Host Microbe; 2017 May; 21(5):569-579.e6. PubMed ID: 28494238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling.
    Gao S; Wang Z; Wang W; Hu X; Chen P; Li J; Feng X; Wong J; Du JX
    J Biol Chem; 2017 Jul; 292(30):12702-12712. PubMed ID: 28588028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.